Voloridge Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Sell
60,844
-45,254
-43% -$1.63M 0.01% 649
2026
Q1
$3.75M Sell
106,098
-104,095
-50% -$4.24M 0.02% 735
2025
Q4
$8.53M Buy
210,193
+101,052
+93% +$4.4M 0.03% 632
2025
Q3
$5.13M Buy
109,141
+12,333
+13% +$639K 0.02% 740
2025
Q2
$5.04M Sell
96,808
-10,804
-10% -$593K 0.02% 749
2025
Q1
$6.5M Buy
107,612
+10,878
+11% +$701K 0.02% 708
2024
Q4
$6.62M Sell
96,734
-43,194
-31% -$3.01M 0.02% 692
2024
Q3
$10.1M Buy
139,928
+571
+0.4% +$40.3K 0.04% 584
2024
Q2
$9.66M Buy
139,357
+77,324
+125% +$5.64M 0.04% 570
2024
Q1
$4.97M Buy
+62,033
New +$5.53M 0.02% 664
2023
Q4
Sell
-4,262
Closed -$430K 1209
2023
Q3
$430K Buy
+4,262
New +$490K ﹤0.01% 1229
2023
Q1
Sell
-10,555
Closed -$936K 1392
2022
Q4
$936K Sell
10,555
-59,704
-85% -$4.95M 0.01% 1147
2022
Q3
$5.63M Sell
70,259
-5,680
-7% -$536K 0.03% 615
2022
Q2
$7.27M Buy
+75,939
New +$9.11M 0.04% 548
2021
Q4
Sell
-24,090
Closed -$3.15M 1605
2021
Q3
$3.15M Buy
24,090
+14,676
+156% +$1.92M 0.02% 872
2021
Q2
$1.29M Buy
+9,414
New +$1.29M 0.01% 1154
2020
Q1
Sell
-19,022
Closed -$2.13M 1129
2019
Q4
$2.13M Buy
19,022
+8,787
+86% +$936K 0.04% 479
2019
Q3
$984K Buy
+10,235
New +$961K 0.02% 645

Other funds holding CNMD

Voloridge Investment Management's CNMD Position: Q2 2026 in Review

Voloridge Investment Management reduced its CONMED (CNMD) stake by 43% in Q2 2026, selling an estimated $1.63M and leaving 60,844 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #649.

Voloridge Investment Management first reported a position in CNMD in Q3 2019 and has held it in 18 quarters since. The position peaked at $10.1M in Q3 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Voloridge Investment Management held 60,844 shares of CONMED worth $1.99M as of Q2 2026.
  • Voloridge Investment Management sold 45,254 CONMED shares in Q2 2026, an estimated $1.63M.
  • CONMED made up 0.01% of Voloridge Investment Management's portfolio in Q2 2026, its #649 holding.
  • Voloridge Investment Management first reported a position in CONMED in Q3 2019 and has held it in 18 quarters since.
  • Voloridge Investment Management's CONMED position peaked at $10.1M in Q3 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.